Search results for: Clinical Trial

Baylor Scott & White researchers launch study to examine the impact of exercise on “long COVID” and COVID-19 recovery

The Centers for Disease Control and Prevention (CDC) has reported that an estimated 140 million Americans have been infected with the SARS-CoV-2 virus based on data collected from blood tests taken through January 2022. Many of these Americans are still feeling the after-effects of the virus known as post-acute sequelae of SARS-CoV-2 (PASC), or “long COVID.” The cases of PASC are becoming so common that lawmakers introduced a bill to fund research into the long-term effects of the disease and expand treatment resources for people experiencing them.

Read more

Research team looks to establish new dementia caregiver support solutions

Caring for family members with dementia and other forms of Alzheimer’s disease is a difficult task, and it is common for caregivers to feel overwhelmed due to the physical and emotional demands of the role. Researchers at Baylor Scott & White Research Institute’s (BSWRI) Center for Applied Health Research (CAHR) are engaged in groundbreaking studies to understand how to improve the quality of life for these caregivers. This work has taken on even greater implications now as COVID-19 creates greater isolation for caregivers making their role even more challenging.

Read more

Next generation total artificial heart as bridge to transplant in landmark trial at BSW

Baylor Scott & White Research Institute was recently selected as one of only seven sites in the nation to participate in the landmark feasibility study of the Carmat Total Artificial Heart (TAH) for transplant-eligible patients in severe, end-stage heart failure. It is also the only site to offer the FDA-approved TAH in the region.

Read more

BSW researcher co-authors paper in JAMA Oncology examining Hypofractionated Image-Guided Radiotherapy (IGRT) for non-small cell lung cancer patients

Concurrent radiation therapy and chemotherapy, known as chemoradiation, is a common treatment for locally advanced cancers. Adding concurrent chemotherapy can improve the effectiveness of radiation therapy but can also enhance the appearance of toxic side effects. This means that some cancer patients, especially those with comorbidities or poor health status, are ineligible for concurrent chemoradiation. Researchers at Baylor Scott & White Research Institute (BSWRI) are contributing to critical clinical trials to improve the effectiveness of radiation therapy for cancer patients, including those who are not eligible for concurrent chemoradiation.

Read more

How do we improve patient outcomes with translational research? By educating our future.

From Bench (to Post-graduate Practitioners) to Bedside

Translational research brings new findings from bench to bedside to expedite improvement in patient outcomes. Baylor Scott & White Research Institute (BSWRI) also brings these findings to lecture halls and conferences to ensure postgraduates are well-informed of the latest findings and “best clinical practices” in their disease specialty.

Read more